EZH2 and cancer: GBM (P=1.13 × 10-2), LIHC (P=1.6 × 10-18), LUAD (P=4.73 × 10-24), and breast cancer (P=4.73 × 10-8) had higher phosphorylation degree in T487 site of EZH2 protein, revealing that protein phosphorylation of EZH2 at T487 site might serve as a facilitator in the development and progression of these cancers (Figure 7C).